Bridge Medicines appoints William J. Polvino as Chief Executive Officer
Saturday, July 12, 2025 - 05:09
in Health & Medicine
As Chief Executive Officer of the newly formed drug discovery company, founded by Rockefeller University and its two neighboring institutions, Polvino will be responsible for building a portfolio of early-stage drug discovery projects and advancing each program from animal proof of principle to clinical trials. More »